100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (PARENTHETICAL) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) (PARENTHETICAL) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100080 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Nature of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - License and Collaboration Agreements link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - Population Health Partners, L.P link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Defined Contribution Plan link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - Convertible Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - Net Loss per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - Nature of Business and Basis of Presentation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - Summary of Significant Accounting Policies - Summary of the impact of the adoption (Details) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 100400 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100410 - Disclosure - Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 100420 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100430 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 100440 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 100450 - Disclosure - License and Collaboration Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100460 - Disclosure - Population Health Partners, L.P (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 100470 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100480 - Disclosure - Commitments and Contingencies - Schedule of Components of Operating Lease Expense (Details) link:presentationLink link:calculationLink link:definitionLink 100490 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 100500 - Disclosure - Convertible Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100510 - Disclosure - Convertible Preferred Stock - Schedule of Preferred Stock (Details) link:presentationLink link:calculationLink link:definitionLink 100520 - Disclosure - Common Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100530 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100540 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Fair Values and Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 100550 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 100560 - Disclosure - Stock-Based Compensation - Schedule of Unvested Common Stock From Option Early Exercises (Details) link:presentationLink link:calculationLink link:definitionLink 100570 - Disclosure - Stock-Based Compensation - Summary of Share Based Compensation Expense Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 100580 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100590 - Disclosure - Defined Contribution Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100600 - Disclosure - Net Loss Per Share - Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) link:presentationLink link:calculationLink link:definitionLink 100610 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 100620 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Convertible Debt, Total Convertible Debt Convertible debt Lessee, Operating Lease, Liability, to be Paid, Year One 2024 Document Transition Report Document Transition Report Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term (In Years) Money Market Fund [Member] Money Market Funds [Member] Research Development And Regulatory Milestone Research Development And Regulatory Milestone [Member] Research development and regulatory milestone. Payments of stock issuance costs Payments of Stock Issuance Costs Number of quarterly installments for vesting succeeding period Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Succeeding Period Share based compensation arrangement by share based payment award vesting number of quarterly installment succeeding period. Adimab Platform Transfer Agreement [Member] Adimab Platform Transfer Agreement [Member] Percentage of eligible participants of non-elective contributions Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage Amount paid for services Amount Paid For Services Amount paid for services Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Award vesting period Debt Securities, Available-for-Sale, Total Debt Securities, Available-for-Sale Securities, available for offer and sale Other Liabilities, Noncurrent Other non-current liability Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Level 1 [Member] Fair Value, Inputs, Level 1 [Member] License Agreements [Abstract] License Agreements. 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four PHP Warrants Outstanding [Member] PHP Warrants Outstanding [Member] Php Warrants Outstanding [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Temporary Equity, Shares Authorized Convertible preferred stock, shares authorized Increase (Decrease) in Other Current Liabilities Other current liabilities Milestone payment Milestone Payment Milestone payment. Prepaid Expense and Other Assets, Current [Abstract] 2020 Equity Incentive Plan Equity Incentive Plan [Member] Equity incentive plan. Title of Individual [Domain] Two Thousand And Twenty Two Employee Stock Purchase Plan Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] Subsequent Events Subsequent Events [Text Block] Temporary Equity, Shares Issued Convertible preferred stock, shares issued Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating lease liability, non-current Operating Lease, Liability, Noncurrent Issuance of Series A convertible preferred stock in exchange for license and common stock, shares Shares repurchased Stock Repurchased During Period, Shares Assets: Assets, Fair Value Disclosure [Abstract] Related Party Transactions [Abstract] Total current assets Assets, Current Total liabilities, preferred stock and stockholders' equity Liabilities and Equity Entity Address, State or Province Entity Address, State or Province Impact of Adoption [Member] Impact of Adoption [Member] Impact of Adoption [Member] Issuance of common stock, net of issuance costs, Value Stock Issued During Period, Value, New Issues Acquired In Process Research And Development Acquired in-process research and development. Acquired in-process research and development Outstanding Outstanding at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Fair value of common stock Per Share Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Purchase Obligation, to be Paid, Remainder of Fiscal Year 2023 (excluding the nine months ended September 30, 2023) Trading Symbol Trading Symbol Common stock, shares issued (in shares) Common Stock, Shares, Issued Common Stock, Shares, Issued, Total Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Exercise of stock options Exercise of stock options Exercise of stock options Net Income (Loss) Attributable to Parent [Abstract] Numerator Cash Equivalents [Member] Cash and Cash Equivalents [Member] Balances, shares Balances, shares Shares, Outstanding Lessee, Operating Lease, Liability, to be Paid, Year Three 2026 AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income [Member] Wu Xi Commercial Manufacturing Services Agreement. Wu Xi Commercial Manufacturing Services Agreement [Member] WuXi Commercial Manufacturing Services Agreement [Member] Entity Address, City or Town Entity Address, City or Town Related Party Transaction [Line Items] Related Party Transaction [Line Items] Common Stock, Conversion Basis Common stock, conversion basis Class of Warrant or Right, Outstanding Exercisable common stock Lease term Lessee, Operating Lease, Renewal Term Prepaid compensation and other Prepaid compensation and related expenses Prepaid Compensation And Related Expenses Subsequent Event Subsequent Event [Member] Subsequent Event Type Subsequent Event Type [Axis] Chief Executive Officer [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Accrued Upfront Fee Accrued Upfront Fee Accrued Upfront Fee. Amortization Cost Amortized Cost Amortization Series B Preferred Stock [Member] Series B Preferred Stock [Member] Current liabilities: Liabilities, Current [Abstract] Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Current assets: Assets, Current [Abstract] Preferred stock par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Statement of Stockholders' Equity [Abstract] Weighted-Average Exercise Price,Vested and expected to vest at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Operating lease liability, current Operating Lease, Liability, Current Marketable Securities Marketable Securities, Policy [Policy Text Block] Earnings Per Share, Basic, Other Disclosure [Abstract] Denominator Property and equipment, net Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Total Series A Preferred Stock [Member] Series A Preferred Stock [Member] Class of Stock Class of Stock [Domain] Two Thousand And Twenty One Employee Stock Purchase Plan Two Thousand And Twenty One Employee Stock Purchase Plan [Member] Two Thousand And Twenty One Employee Stock Purchase Plan Member Aggregate Intrinsic Value, Vested and Expected to vest at JMarch 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Unrealized Gains Unrealized Gains Unrealized Gain on Marketable Securities Unrealized Gain on Marketable Securities Statement of Comprehensive Income [Abstract] Scenario [Domain] Treasury Stock, Common, Shares Treasury Stock, Common, Shares Entity Central Index Key Entity Central Index Key Cell Line License Agreement [Member] Wu Xi Cell Line License Agreement [Member] WuXi Cell Line License Agreement. Plan Name Plan Name [Domain] Assets, fair value disclosure Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Total current liabilities Liabilities, Current Entity Tax Identification Number Entity Tax Identification Number Due From Related Party Due From Related Party Due from Related Party Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Optimization Completion Fee Optimization Completion Fee. Optimization Completion Fee Optimization Completion Fee Payments for offering costs Payments for offering costs Payments for offering costs Payments for offering costs Adimab [Member] Adimab [Member] Adimab [Member] Carrying Value Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value Common stock, $0.0001 par value; 1,000,000,000 shares authorized,109,773,173 shares issued and 108,780,525 shares outstanding at June 30, 2022; 1,000,000,000 shares authorized, 111,251,660 shares issued and 110,782,909 shares outstanding at December 31, 2021 Issuance of common stock under the employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Award Type Award Type [Axis] Restricted Stock [Member] Restricted Stock [Member] Other Commitments [Abstract] Plan Name Plan Name [Axis] Total assets Assets Operating lease right-of-use asset Operating Lease, Right-of-Use Asset Series C Convertible Preferred Stock [Member] Series C convertible preferred stock. Series C Convertible Preferred Stock [Member] Liability for unvested shares Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Fifteen November Two Thousand Twenty Eight Member Fifteen November Two Thousand Twenty Eight Member November 15, 2028 [Member] Acquired IPR&D expense Acquired In Process Research And Development Expense Acquired in-process research and development expense. Retirement Plan Name Retirement Plan Name [Domain] Entity Registrant Name Entity Registrant Name Entity Address, Address Line Three Entity Address, Address Line Three Related Party Related Party, Type [Domain] Accumulated Deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization, Consolidation and Presentation of Financial Statements line items. Accumulated Deficit [Member] Retained Earnings [Member] Class of Stock Class of Stock [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Beginning Balance at December 31, 2022 Ending Balance at September 30, 2023 Payment for Pension and Other Postretirement Benefits [Abstract] Cash paid for amounts included in the measurement of lease liabilities: Issuance of common stock under the employee stock purchase plan, shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Minimum [Member] Minimum [Member] Minimum Proceeds from exercises of stock options Proceeds from Stock Options Exercised Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Present value of operating lease liability Present value of operating lease liability Operating Lease, Liability Operating cash flows related to operating leases Equity Component Equity Component [Domain] Defined contribution amount Defined Contribution Plan, Cost Employee Stock Option [Member] Share-Based Payment Arrangement, Option [Member] Convertible preferred stock outstanding converted into common stock Conversion of Stock, Shares Converted Two Thousand And Twenty Employee Stock Purchase Plan Member Two Thousand And Twenty Employee Stock Purchase Plan Member Two Thousand And Twenty Employee Stock Purchase Plan ATM Facility [Member] ATM Facility [Member] Convertible Preferred Stock, Shares Reserved for Future Issuance Convertible preferred stock shares reserved for future issuance Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Measurement Frequency Measurement Frequency [Axis] A&R Commercial Manufacturing Agreement A And R Commercial Manufacturing Agreement [Member] A And R Commercial Manufacturing Agreement [Member] Marketable Securities [Abstract] Entity Current Reporting Status Entity Current Reporting Status Common stock, shares authorized (in shares) Common Stock, Shares Authorized Research and development expense Research and Development Expense Research and Development Expense, Total Research and development Assets [Abstract] Assets Proceeds from issuance of common stock under the employee stock purchase plan Proceeds from Issuance of Common Stock Inventory Schedule of Utility Inventory [Table Text Block] Capitalized software in accrued expenses Capitalized software in accrued expenses Capitalized software in accrued expenses Shares available for future issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Interest receivable Interest Receivable, Current Convertible Preferred Stock [Member] Convertible Preferred Stock Member Common stock, $0.0001 par value; 1,000,000,000 shares authorized, 119,221,230 shares issued and outstanding at March 31, 2024; 110,160,684 shares issued and outstanding at December 31, 2023 Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than) Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Percentage Of Fair Value Of Common Stock Share based compensation arrangement by share based payment award options exercise price percentage of fair value of common stock. Accrued Liabilities, Current, Total Accrued expenses Accrued Liabilities, Current Current Fiscal Year End Date Current Fiscal Year End Date Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Loss from operations Loss from operations Operating Income (Loss) Research and Developmet Expenses Research and Developmet Expenses Research and developmet expenses Entity Ex Transition Period Entity Ex Transition Period Income tax expense (benefit) Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Weighted-average remaining contractual term (Years) Research and Development Expense [Member] Research and Development [Member] Research and Development Expense [Member] Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations Contractual Obligation, Fiscal Year Maturity [Table Text Block] Leases Lessee, Leases [Policy Text Block] Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Stock based compensation expense Share-Based Payment Arrangement, Expense Percentage of options vesting Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Recognized research and development Other Research and Development Expense Operating lease liabilities Increase (Decrease) in Operating Lease Liability Payments to acquire royalty Payments To Acquire Royalty Payments to Acquire Royalty. Deferred offering and issuance cost included in accrued expenses Deferred offering and issuance cost included in accrued expenses Retirement of treasury shares, shares Treasury Stock, Shares, Retired Aggregate Intrinsic Value, Outstanding at March 31, 2024 Aggregate Intrinsic Value, Outstanding at June 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Common shares repurchased Sale of stock, price per share Sale of Stock, Price Per Share Related party expenses Costs and Expenses, Related Party Quarterly fee Quarterly Fee Quarterly Fee. Operating expenses: Operating Expenses [Abstract] Unrealized gain on available-for-sale securities, net of tax Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total Proceeds from License Fees Received License fees received Subsequent Events [Abstract] Commitments and Contingencies Disclosure [Abstract] Other non-current assets Other Assets, Noncurrent Other Assets, Noncurrent, Total Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Common Stock Equity [Text Block] Agency Securities [Member] Federal Agency Securities [Member] Depreciation expense Depreciation Depreciation, Total Series A Convertible Preferred Stock [Member] Series A convertible preferred stock. Series A Convertible Preferred Stock [Member] Undesignated preferred stock capital shares reserved for future issuance UndesignatedPreferredStockCapitalSharesReservedForFutureIssuance Undesignated preferred stock capital shares reserved for future issuance. Stockholders' equity (deficit): Equity, Attributable to Parent [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Schedule of Components of Operating Lease Expense Lease, Cost [Table Text Block] Security for sale offering Partners' Capital Account, Public Sale of Units Net of Offering Costs PHP Member PHP Member Earnings Per Share [Abstract] Operating lease right-of-use asset recognized Operating lease right-of-use asset recognized Subordinated Borrowing, Interest Rate Borrowing rate Accounting Policies [Abstract] Second Product [Member] Second Product [Member] Second Product. In Process Research and Development [Member] In Process Research and Development [Member] Scenario [Axis] Sale of Stock, Consideration Received on Transaction Purchase price of shares Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of quarterly installments for vesting Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Share based compensation arrangement by share based payment award vesting number of quarterly installment. Schedule of Supplemental Information Related to Operating Leases Supplemental Cash Flow Information Operating Lease [Table Text Block] Supplemental Cash flow information operating lease. Long-Term Purchase Commitment [Table] Repurchased Repurchased Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Repurchased In Period Share based compensation arrangement by share based payment award equity instruments other than options repurchased in period. Net loss per share attributable to common stockholders, basic Earnings Per Share, Basic, Total Earnings Per Share, Basic Schedule of Cash and Cash Equivalents [Table] Commitments and contingencies (Note 8) Total cost incurred Commitments and Contingencies Related Party Related Party, Type [Axis] Early-exercise liability Early Exercise Liability Early-exercise liability. Operating lease cost Operating Lease, Cost Retirement Benefits [Abstract] Vested and expected to vest at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Statistical Measurement Statistical Measurement [Domain] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash fees Cash Fees Fees to be paid in cash Award Type All Award Types Royalty percentage of sublicense consideration Royalty Percentage Of Sublicense Consideration Royalty, Percentage of Sublicense Consideration. Document Period End Date Document Period End Date Statistical Measurement Statistical Measurement [Axis] Potential milestone payment Potential Milestone Payment Potential milestone payment. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Prepaid Expenses and Other Current Assets Prepaid Expenses Other Current Assets [Text Block] The entire disclosure for prepaid expenses and other current assets. Operating cash flows related to operating leases Operating Lease, Payments Net loss per share attributable to common stockholders,diluted Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Product and Service Product and Service [Domain] Cash paid for amounts included in the measurement of lease liabilities: Lease, Cost [Abstract] Lease cost Convertible preferred stock, net of issuance costs Net Issuance Cost Of Convertible Preferred Stock Net issuance cost of convertible preferred stock. Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Options exercisable at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Related Party Transaction Related Party Transaction [Domain] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Transfers between level 3 Fair Value Transfers Between Levels Transfers Amount Fair value transfers between levels transfers amount. Sales Agreement [Member] Sales Agreement [Member] Sales Agreement [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] US Treasury Securities [Member] U.S. Treasury Securities [Member] Preferred stock original issue and conversion price, per share Preferred Stock Original Issue And Conversion Price Per Share Preferred stock original issue and conversion price per share. Adimab Collaboration Agreement [Member] Adimab Collaboration Agreement [Member] Adimab Collaboration Agreement. Other Commitment Disclosure [Text Block] Other Commitment Disclosure [Text Block] Population Health Partners, L.P Finite-Lived Intangible Assets, Major Class Name Finite-Lived Intangible Assets, Major Class Name [Domain] Exercised Exercise of stock options, shares Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit) Liabilities and Equity [Abstract] Shelf Registration Statement [Member] Shelf Registration Statement [Member] Shelf Registration Statement [Member] Present value of operating lease liability Present value of operating lease liability Present value of operating lease liability Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Acquired In Process Research And Development Expense [Member] Acquired In Process Research And Development Expense [Member] Acquired In Process Research And Development Expense [Member] Accounts payable Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Payable, Total Credit Facility [Domain] Other non-current liability Other non-current liability Other Deferred Compensation Arrangements, Liability, Current and Noncurrent Equity [Abstract] Issued Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted-Average Exercise Price, Exercised Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Equity Components Equity Components [Axis] First Product [Member] First Product [Member] First Product. Option Exercise Fee Option Exercise Fee Option Exercise Fee Related Party Transaction Expenses From Transaction With Related Party Related Party Transaction Expenses From Transaction With Related Party Related Party Transaction Expenses From Transaction With Related Party Fifteen November Two Thousand Thirty [Member] Fifteen November Two Thousand Thirty [Member] November 15, 2030 [Member] Local Phone Number Local Phone Number Sale of Stock Sale of Stock [Axis] Weighted-Average Exercise Price,Options exercisable at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Fifteen November Two Thousand Twenty Nine [Member] Fifteen November Two Thousand Twenty Nine [Member] November 15, 2029 [Member] Present value adjustment Present value adjustment Present value adjustment Defined Contribution Plan [Table] Defined Contribution Plan [Table] Proceeds from issuance of preferred stock Proceeds from Issuance of Preferred Stock and Preference Stock Statement of Cash Flows [Abstract] Repurchase of unvested restricted common stock Stock Repurchased and Retired During Period, Shares Repurchase of unvested restricted common stock, shares Advance potential milestone payment Advance payment Advance Potential Milestone Payment Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive loss 2024 (excluding the three months ended March 31, 2024) Purchase Obligation, to be Paid, Year One Common stock, par value Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Accrued professional and consultant fees Accrued Professional Fees Due To Related Parties Due To Related Parties Due To Related Parties Cumulative Effect, Period of Adoption [Axis] Unrecognized stock based compensation expense, Weighted average recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted Average Remaining Contractual Term, Vested and Expected to vest at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Number of shares of common stock authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Collaborative Arrangement Disclosure [Text Block] License and Collaboration Agreements Maximum [Member] Maximum [Member] Emerging Growth Company Emerging Growth Company Policy [Text Block] Emerging Growth Company Retirement Plan Name Retirement Plan Name [Axis] Temporary Equity, Shares Outstanding Convertible preferred stock, shares outstanding Related Party Transaction Related Party Transaction [Axis] IPR&D Expense [Member] In Process Research And Development Expense [Member] IPR&D expense. Nature of the Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value Adjustment of Warrants Warrant expense Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Completion fee Completion Fee Completion Fee. Selling, General and Administrative [Member] General and Administrative Expense [Member] Noncash Investing and Financing Items [Abstract] Supplemental disclosure of cash flow information Research And Developments In Process Research And Developments In Process Research and development expenses Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Accounts payable and accrued expenses Accrued Liabilities Accrued expenses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share City Area Code City Area Code Inventory Inventory, Net Inventory, Net, Total Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Marketable Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Future minimum payments under non-cancelable purchase obligations Operating Leases, Future Minimum Payments Due Operating Leases, Future Minimum Payments Due, Total Unrealized Losses Unrealized Loss on Marketable Securities Unrealized loss on marketable securities. Defined Contribution Plan Defined Contribution Plan [Text Block] Temporary Equity, Liquidation Preference Convertible preferred stock, liquidation preference Weighted-average common shares outstanding, basic Weighted-average common shares outstanding, basic and diluted Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Other Commitments [Line Items] 401(k) Plan Four Hundred One K Plan [Member] Four Hundred One K Plan Member Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Percentage of Commision Paid, Gross Proceeds From Future Sales Percentage of Commision Paid, Gross Proceeds From Future Sales Percentage of commision paid, Gross proceeds from future sales Statement [Table] Statement [Table] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule Of Related Party Transactions By Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Weighted Average Fair Values and Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Total lease payments Lessee, Operating Lease, Liability, to be Paid Related Party Transactions Related Party Transactions Disclosure [Text Block] Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Statement [Line Items] Statement [Line Items] Amount Paid As Pre Paid Funding For Research Plan Amount Paid As Pre Paid Funding For Research Plan Amount Paid As Pre Paid Funding For Research Plan Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Other Other Accrued Liabilities Total lease cost Lease, Cost Royalty expense Royalty Expense Asset Class Asset Class [Domain] Cumulative Effect, Period of Adoption [Domain] Common Stock [Member] Common Stock [Member] Inventory in accrued expenses Inventory in accrued expenses Inventory in accrued expenses Revenue From Related Party Revenue From Related Party Other Commitments [Table] Common stock shares held Common Stock, Shares Held in Employee Trust, Shares Mithril Group [Member] Mithril Group [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Issuance of Series A convertible preferred stock in exchange for license and common stock Issuance of Series A convertible preferred stock in exchange for license and common stock Shares repurchased, Fair value Stock Repurchased During Period, Value Summary of Share Based Compensation Expense Recognized Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Aggregate Intrinsic Value, Exercisable at March 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Net amortization of premiums and accretion of discounts on marketable securities Net amortization of premiums and accretion of discounts on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Antidilutive Securities, Name [Domain] Entity Bankruptcy Proceedings, Reporting Current Entity Bankruptcy Proceedings, Reporting Current Treasury stock, at cost; 0 shares and 468,751 shares at September 30, 2022 and December 31, 2021, respectively Treasury Stock, Value, Total Treasury stock Treasury stock Treasury Stock, Value Cover [Abstract] Selling, general and administrative Selling, General and Administrative Expense Selling, General and Administrative Expense, Total Document Fiscal Year Focus Document Fiscal Year Focus Sale of Stock Sale of Stock [Domain] TSRI The Scripps Research Institute [Member] The scripps research institute member. Security Exchange Name Security Exchange Name Share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Lease space Lessee, Operating Lease, Total Lease Space Lessee, operating lease total lease space. Annual fee Annual Fee Annual Fee New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued and Adopted Accounting Pronouncements Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Preferred Stock, Shares Issued, Total Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Operating lease right-of-use asset recognized upon adoption of ASC 842 Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted-Average Exercise Price,Forfeited Accrued employee compensation Accrued Employee Benefits, Current Recognized expense Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized Accrued external research, development and manufacturing costs Accrued External Research Development And Manufacturing Expenses Current Accrued external research development and manufacturing expenses. Exercise of stock options Vesting of restricted common stock from early-exercised options Stock Issued During Period, Value, Stock Options Exercised Entity Emerging Growth Company Entity Emerging Growth Company Exercise fee Exercise Fee Exercise Fee. Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Organization, Consolidation and Presentation of Financial Statements. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value of stock options exercised Convertible preferred Stock Shares Issued Upon Conversion Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Convertible Preferred Stock, Shares Issued upon Conversion Other income, net Other Nonoperating Gains (Losses) Amendment Flag Amendment Flag Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Annual gross revenue Annual gross revenue Annual gross revenue IPO [Member] IPO [Member] Prepaid external research, development and manufacturing costs Prepaid External Research Development And Manufacturing Expense Current Prepaid external research development and manufacturing expenses. Entity File Number Securities Act File Number Adimab Assignment Agreement [Member] Adimab Assignment Agreement [Member] Adimab Assignment Agreement. Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Summary of the impact of the adoption Summary of impact of the adoption [table text block] Schedule of impact of the adoption [table text block] Share-Based Payment Arrangement [Abstract] Accounts payable Accounts Payable, Current Accounts Payable, Current, Total Proceeds from issuance of common stock, net of issuance costs Proceeds from issuance of common stock, net of issuance costs Proceeds from issuance of common stock, net of issuance costs Expenses Costs and Expenses Costs and Expenses, Total Total operating expenses Operating Expenses Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Entity Address, Address Line Two Entity Address, Address Line Two Preferred stock (undesignated), $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding at March 31, 2024 and December 31, 2023 Carrying Value Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Ending Balance Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Schedule of Unvested Common Stock Options Schedule of Nonvested Share Activity [Table Text Block] Title of Individual [Axis] Sale of Stock, Number of Shares Issued in Transaction Number of shares issued Investment Type Investment Type [Axis] Class of Warrant or Right, Exercise Price of Warrants or Rights Weighted average exercise price of Warrant Per Share Warrant exercise price Class of Warrant or Right [Domain] Purchase Obligation, to be Paid, Year Two 2025 Net Loss Per Share Earnings Per Share [Text Block] Entity Address, Address Line One Entity Address, Address Line One Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Antidilutive Securities [Axis] Other current liability Other Liabilities, Current Summary of Prepaid Expenses and Other Current Assets Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block] Tabular disclosure of the carrying amounts of prepaid expenses and other current assets. Research and Development Arrangement [Member] Subsequent Event Type Subsequent Event Type [Domain] Schedule of Preferred Stock Schedule of Stock by Class [Table Text Block] Income Statement Location Income Statement Location [Axis] Variable lease cost Variable Lease, Cost Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Commission On Sales Commission On Sales Commission On Sales Prepaid insurance Prepaid Insurance Purchases of property and equipment in accounts payable and accrued expenses Fixed asset purchases in account payable and accrued expenses Fixed asset purchases in account payable and accrued expenses Series C Preferred Stock [Member] Series C Preferred Stock [Member] Level 2 [Member] Fair Value, Inputs, Level 2 [Member] Repurchased common stock, per share Share Price Monthly rental payments Sale Leaseback Transaction, Monthly Rental Payments Royalty Based on Net Sales of Licensed Products, Percentage Royalty Based On Net Sales Of Licensed Products Percentage Royalty Based on Net Sales of Licensed Products, Percentage. Product and Service Product and Service [Axis] Federal agency securities [Member] Federal agency securities [Member] Federal Agency Securities [Member] Unaudited Interim Financial Information Unaudited Interim Financial Information Policy [Text Block] Unaudited Interim Financial Information Combined voting power on all classes of stock threshold Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Voting Interests Threshold share based compensation arrangement by share based payment award percentage of voting interests threshold. Title of 12(b) Security Title of 12(b) Security Investments Investments [Domain] Fair Value Assets, Fair Value Adjustment Fair Value Available for sale marketable securities Available for sale marketable securities Available for sale marketable securities Treasury Stock, Common [Member] Treasury Stock [Member] Cantor Fitzgerald & Co [Member] Cantor Fitzgerald & Co [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Inventory Inventory Increase (Decrease) in Inventories Increase (Decrease) in Inventories, Total Purchase Obligation Purchase Obligation Total lease payments Cash fee payment per month Cash fee payment per month Cash and Cash Equivalents Cash and Cash Equivalents [Axis] Present value adjustment Present value adjustment Operating Lease Liability Adjustment Operating lease liability adjustment. Weighted Average Remaining Contractual Term, Exercisable at JMarch 31, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share Based Compensation Share-Based Payment Arrangement [Text Block] Non cash payments Non cash payments Non-cash payments VYD Two Hundred Twenty Two DrugSubstance [Member] VYD Two Hundred Twenty Two DrugSubstance [Member] VYD222 Drug Substance Other Commitment, Total Other Commitment Aggregate fee Drug Delivery Fee Drug Delivery Fee Drug Delivery Fee Income Statement Location Income Statement Location [Domain] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-Average Exercise Price, Granted PHP Warrant [Member] PHP Warrant [Member] Document Type Document Type Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net cash provided by (used in) investing activities Document Quarterly Report Document Quarterly Report Other comprehensive income (loss) Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract] Long-Term Purchase Commitment [Line Items] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Entity Filer Category Entity Filer Category Other non-current assets Increase (Decrease) in Other Noncurrent Assets Other non-current assets Accrued expenses Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Accrued Liabilities, Total ADG20 Drug Substance [Member] A D G20 Drug Substance [Member] A D G20 Drug Substance Delivery fee Delivery Fee Delivery Fee. Purchase of marketable securities Purchase of marketable securities Payments to Acquire Marketable Securities Asset Class Asset Class [Axis] Total other income, net Nonoperating Income (Expense) Total liabilities Liabilities Total stockholders' equity Balances Balances Equity, Attributable to Parent Accrued Liabilities [Abstract] Net Income (Loss) Net loss attributable to common stockholder Net loss Net Income (Loss) Other income: Nonoperating Income (Expense) [Abstract] Cash and Cash Equivalents [Domain] Convertible Preferred Stock Preferred Stock [Text Block] Statement of Financial Position [Abstract] Weighted-average common shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Purchase Obligation, to be Paid, Year Three 2026 Credit Facility [Axis] Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of operating lease right-of-use assets Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Use of Estimates Use of Estimates, Policy [Policy Text Block] Income Taxes Income Tax Disclosure [Text Block] Shares issued, Fair value Preferred Stock Fair Value Preferred Stock, Fair Value. Weighted-Average Exercise Price, Beginning Balance at December 31, 2023(Per Share) Weighted-Average Exercise Price, Ending Balance at June 30, 2023 (Per Share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Population Health Partners [Member] Population Health Partners [Member] PHP Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Percentage of number of shares of common stock outstanding Percentage Of Total Number Of Shares Of Common Stock Outstanding Percentage Of Total Number Of Shares Of Common Stock Outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share LineItems Fair Value Disclosures [Abstract] 2021 Equity Incentive Plan Two Thousands Twenty One Equity Incentive Plan [Member] Two Thousands Twenty One Equity Incentive Plan [Member] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Measurement Frequency Measurement Frequency [Domain] Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Vested Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Issuance of common stock, net of issuance costs, Shares Issuance of common stock, shares Stock Issued During Period, Shares, New Issues Class of Warrant or Right [Axis] Maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Proceeds from Sale and Maturity of Marketable Securities, Total Income Tax Disclosure [Abstract] Finite-Lived Intangible Assets by Major Class Finite-Lived Intangible Assets by Major Class [Axis] Summary of Marketable Securities Marketable Securities [Table Text Block]